HRT Financial’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-44,243
| Closed | -$202K | – | 3274 |
|
|
2025
Q1 | $202K | Buy |
44,243
+13,453
| +44% | +$61.4K | ﹤0.01% | 1802 |
|
|
2024
Q4 | $173K | Sell |
30,790
-96,069
| -76% | -$540K | ﹤0.01% | 1759 |
|
|
2024
Q3 | $613K | Buy |
+126,859
| New | +$613K | ﹤0.01% | 1373 |
|
|
2024
Q1 | – | Sell |
-22,267
| Closed | -$310K | – | 2962 |
|
|
2023
Q4 | $310K | Buy |
+22,267
| New | +$310K | ﹤0.01% | 1476 |
|
|
2023
Q3 | – | Sell |
-12,669
| Closed | -$237K | – | 2884 |
|
|
2023
Q2 | $237K | Sell |
12,669
-1,263
| -9% | -$23.6K | ﹤0.01% | 1589 |
|
|
2023
Q1 | $200K | Buy |
+13,932
| New | +$200K | ﹤0.01% | 1752 |
|
|
2022
Q3 | – | Sell |
-36,541
| Closed | -$558K | – | 3376 |
|
|
2022
Q2 | $558K | Buy |
+36,541
| New | +$558K | 0.01% | 1368 |
|
|
2021
Q3 | – | Sell |
-62,159
| Closed | -$3.75M | – | 3539 |
|
|
2021
Q2 | $3.75M | Buy |
+62,159
| New | +$3.75M | 0.03% | 366 |
|